KCC1 Activation protects Mice from the Development of Experimental Cerebral Malaria

Sci Rep. 2019 Apr 23;9(1):6356. doi: 10.1038/s41598-019-42782-x.

Abstract

Plasmodium falciparum malaria causes half a million deaths per year, with up to 9% of this mortality caused by cerebral malaria (CM). One of the major processes contributing to the development of CM is an excess of host inflammatory cytokines. Recently K+ signaling has emerged as an important mediator of the inflammatory response to infection; we therefore investigated whether mice carrying an ENU induced activation of the electroneutral K+ channel KCC1 had an altered response to Plasmodium berghei. Here we show that Kcc1M935K/M935K mice are protected from the development of experimental cerebral malaria, and that this protection is associated with an increased CD4+ and TNFa response. This is the first description of a K+ channel affecting the development of experimental cerebral malaria.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • CD4-Positive T-Lymphocytes / immunology
  • CD8-Positive T-Lymphocytes / immunology
  • Cytokines / metabolism
  • Disease Resistance
  • Female
  • Inflammation Mediators / metabolism
  • Ion Channel Gating*
  • Malaria, Cerebral / immunology
  • Malaria, Cerebral / metabolism*
  • Malaria, Cerebral / parasitology
  • Malaria, Cerebral / prevention & control*
  • Male
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Mutation / genetics
  • Plasmodium berghei / physiology
  • Solute Carrier Family 12, Member 4 / genetics
  • Solute Carrier Family 12, Member 4 / metabolism*

Substances

  • Cytokines
  • Inflammation Mediators
  • Solute Carrier Family 12, Member 4